CME Financial Statements (CME)
|
|
|
|
Report date
|
|
|
27.02.2023 |
31.12.2023 |
28.02.2024 |
27.02.2025 |
26.02.2026 |
|
24.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
5 019 |
5 579 |
5 579 |
6 130 |
6 521 |
|
6 758 |
|
Operating Income, bln rub |
|
|
3 016 |
3 436 |
3 436 |
3 932 |
4 230 |
|
4 431 |
|
EBITDA, bln rub |
? |
|
4 016 |
3 788 |
4 666 |
5 039 |
5 720 |
|
5 688 |
|
Net profit, bln rub |
? |
|
2 691 |
3 186 |
3 226 |
3 526 |
4 044 |
|
4 243 |
|
|
OCF, bln rub |
? |
|
3 056 |
705.2 |
3 454 |
3 691 |
4 277 |
|
4 420 |
|
CAPEX, bln rub |
? |
|
89.7 |
0.000 |
76.4 |
94.0 |
83.5 |
|
91.1 |
|
FCF, bln rub |
? |
|
2 966 |
705.2 |
3 377 |
3 597 |
4 194 |
|
4 329 |
|
Dividend payout, bln rub
|
|
|
2 634 |
0.000 |
3 236 |
3 584 |
3 933 |
|
4 063 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
97.9% |
0.00% |
100.3% |
101.7% |
97.2% |
|
95.8% |
|
|
OPEX, bln rub |
|
|
1 250 |
1 105 |
1 315 |
1 348 |
1 384 |
|
1 404 |
|
Cost of production, bln rub |
|
|
753.1 |
1 039 |
828.6 |
850.3 |
907.0 |
|
923.3 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
162.7 |
159.4 |
159.4 |
160.9 |
129.7 |
|
131.6 |
|
|
Assets, bln rub |
|
|
174 176 |
129 706 |
129 706 |
137 447 |
198 548 |
|
201 994 |
|
Net Assets, bln rub |
? |
|
26 879 |
26 738 |
26 738 |
26 487 |
28 728 |
|
26 618 |
|
Debt, bln rub |
|
|
3 438 |
3 425 |
3 425 |
3 428 |
3 757 |
|
3 423 |
|
Cash, bln rub |
|
|
2 816 |
3 029 |
3 024 |
3 006 |
4 548 |
|
2 515 |
|
Net debt, bln rub |
|
|
622.3 |
396.5 |
401.7 |
422.4 |
-791.2 |
|
907.8 |
|
|
Ordinary share price, rub |
|
|
168.2 |
210.6 |
210.6 |
232.2 |
273.1 |
|
290.4 |
|
Number of ordinary shares, mln |
|
|
358.7 |
359.5 |
359.0 |
359.4 |
359.6 |
|
359.3 |
|
|
Market cap, bln rub |
|
|
60 321 |
75 711 |
75 610 |
83 461 |
98 209 |
|
104 333 |
|
EV, bln rub |
? |
|
60 943 |
76 107 |
76 012 |
83 883 |
97 417 |
|
105 241 |
|
Book value, bln rub |
|
|
-4 049 |
16 243 |
-3 983 |
-3 997 |
-1 573 |
|
-1 063 |
|
|
EPS, rub |
? |
|
7.50 |
8.86 |
8.99 |
9.81 |
11.2 |
|
11.8 |
|
FCF/share, rub |
|
|
8.27 |
1.96 |
9.41 |
10.0 |
11.7 |
|
12.0 |
|
BV/share, rub |
|
|
-11.3 |
45.2 |
-11.1 |
-11.1 |
-4.37 |
|
-2.96 |
|
|
EBITDA margin, % |
? |
|
80.0% |
67.9% |
83.6% |
82.2% |
87.7% |
|
84.2% |
|
Net margin, % |
? |
|
53.6% |
57.1% |
57.8% |
57.5% |
62.0% |
|
62.8% |
|
FCF yield, % |
? |
|
4.92% |
0.93% |
4.47% |
4.31% |
4.27% |
|
4.15% |
|
ROE, % |
? |
|
10.0% |
11.9% |
12.1% |
13.3% |
14.1% |
|
15.9% |
|
ROA, % |
? |
|
1.54% |
2.46% |
2.49% |
2.57% |
2.04% |
|
2.10% |
|
|
P/E |
? |
|
22.4 |
23.8 |
23.4 |
23.7 |
24.3 |
|
24.6 |
|
P/FCF |
|
|
20.3 |
107.4 |
22.4 |
23.2 |
23.4 |
|
24.1 |
|
P/S |
? |
|
12.0 |
13.6 |
13.6 |
13.6 |
15.1 |
|
15.4 |
|
P/BV |
? |
|
-14.9 |
4.66 |
-19.0 |
-20.9 |
-62.5 |
|
-98.1 |
|
EV/EBITDA |
? |
|
15.2 |
20.1 |
16.3 |
16.6 |
17.0 |
|
18.5 |
|
Debt/EBITDA |
|
|
0.15 |
0.10 |
0.09 |
0.08 |
-0.14 |
|
0.16 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
|
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
1.79% |
0.00% |
1.37% |
1.53% |
1.28% |
|
1.35% |
|
| CME shareholders |
